Common diabetes drugs could combat depression
Diabetes is believed to significantly increase the risk of mood disorders such as depression. But researchers in Taiwan say this risk falls by more than 50 per cent in patients who use metformin to manage their condition.
The researchers from Monash University and the National Health Research Institutes Taiwan conducted a large 12-year study based on a Taiwanese adult population cohort.
They found that people with type 2 diabetes who took metformin were less likely to develop mood disorders, as well as dementia and Parkinson's disease, particularly if used in combination with a sulfonylurea - another commonly used type 2 diabetes drug.
Lead author of the study, Professor Mark Wahlqvist from Monash University's Department of Epidemiology and Preventive Medicine and the Monash Asia Institute: "In earlier research we found that dementia and Parkinson's disease, the most common forms of known neurodegenerative disease, are more likely after the onset of diabetes.
"The same appears to be so for mood disorders including all forms of depression. We found depression and diabetes are more likely to occur together than would be expected from their respective separate prevalences.
"It is possible that neurodegenerative processes are at work in diabetes-associated depression and that the use of metformin may minimise this risk."
He added: "As the global burden of diabetes to health care systems increases, these findings may be relevant to the reduction of mental health complications associated with diabetes."
The research appears online in the medical journal BMC Medicine .
Also related to this storyHypoglycemia
Types of diabetes
Blood glucose and diabetes care
Medication for diabetes
Alternative diabetes treatments
Diabetes nutrition, diet and recipes
Exercise guides for diabetes
Diabetes and the body
Diabetes tools and calculators
NHS diabetes care
Read the latest diabetes news
More than 40m diabetes drugs prescribed in 2011/12
Type 2 diabetes drugs raise bladder cancer risk
Diabetes drugs deliver strong results for Novo Nordisk
Janssen to assist development of regenerative diabetes drugs
GSK fined GBP1.9bn for illegal off-label marketing of drugs
Prescription diabetes drugs may be sold over the counter in US
Diabetes combination drugs receive approval in the US
Antipsychotic drugs can lead to diabetes according to research
Diabetes drugs effect chances of pancreatic cancer, says new study
Diabetes drugs among those causing most hospitalisations in the US
Antipsychotic drugs could increase diabetes risk
Partnership launched to find new diabetes insulin drugs
Combination of drugs may hit diabetics, says report
Anti-seizure drugs could help relieve nerve pain for diabetics
Patient concern over diabetes drugs being banned from NHS prescriptions
Diabetes drugs could help combat addictions
Increase in prescription costs for diabetes drugs in US
Diabetes drugs could help combat lung cancer
New diabetes drugs being developed
Diet and exercise better than drugs for reducing heart risks in diabetics
Popular Cholesterol drugs increase diabetes risk